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Results: All isolates tested in this study contained an OXA-
1-like gene. Additional genotypes are listed below.
N TIG MIC50
(mcg/ml)
TIG MIC50
(mcg/ml)
Range
XA-23 161 1 2 0.12-4
XA-40 39 0.5 1 0.25-4
XA-58 107 0.5 1 0.12-4
SAbal-OXA-51 190 1 2 0.12-4
Conclusion: Tigecycline demonstrated excellent in vitro
ctivity against carbapenem resistant A. baumannii regard-
ess of carbapenemase type. Tigecycline’s in vitro activity
gainst isolates with either intrinsic ISAba1-OXA-51 or the
cquired oxacillinases (OXA-23, OXA-40 and OXA-58) sug-
ests that it may be effective against resistant isolates of
his clinically important pathogen.
oi:10.1016/j.ijid.2010.02.1565
3.010
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Background: Acinetobacter baumannnii has emerged
s a major nosocomial pathogen causing outbreaks of
nfection in the immunosuppressed and critically ill world-
ide. A number of molecular typing techniques have
een developed for use in both local surveillance and
lobal epidemiological studies. We applied a recently
escribed multi-locus sequence typing (MLST) scheme to
ulti-drug resistant A. baumannii (MDRAB) recovered from
ondon Hospitals in comparison with other molecular
ethods.
Methods: Sixteen MDRAB were identiﬁed using multiplex
CR for OXA-carbapenemases and included representatives
reviously assigned to the UK ‘South East’, OXA-23 (1) and
XA-23 (2) clones. Stains were typed using pulsed ﬁeld gel
lectrophoresis (PFGE), randomampliﬁed polymorphic DNA-
CR (RAPD), a multiplex PCR typing (MPT) scheme (ompA,
suE and blaOXA-51 like genes) and an A. baumannii MLST
cheme (gltA, gyrB, gdhB, recA, cpn60, gpi, rpoD).
Results: Five clearly distinguishable proﬁles were
bserved using PFGE and six with RAPD. MPT typing assigned
ll but one of the strains (OXA-23 (2) representative) to
roup 1. Four allelic proﬁles (sequence types ST) were
btained using MLST, two of which appeared to be novel.
omparison of results revealed isolates designated ‘South
ast’ clone by PFGE / RAPD belonged to the previously
escribed ST22 and those designated OXA-23 (1) to ST53.
he allelic proﬁle of the OXA-23 clone 2 strain was novel
nd contained a new gyrB allele.
Conclusion: Molecular techniques were comparable for
yping UK MDRAB. Isolates belonging to ST22, (found pre-
iously in Italy, Portugal, Czech Republic, China, Korea
nd Australia) and isolates belonging to ST53 (found previ-
usly in Italy) were the most frequently types, highlighting
he widespread dissemination of these clones. Two novel
t
c
dternational Congress on Infectious Diseases (ICID) Abstracts
equence types were identiﬁed and are undergoing further
nvestigation.
oi:10.1016/j.ijid.2010.02.1566
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Shaheed Beheshti Medical University, Tehran, Iran, Islamic
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Shaheed Beheshti Medical University, tehran, Iran, Islamic
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Background: Acinetobacter baumannii is a multi drug
esistant organism associated with high morbidity and mor-
ality. It is an emerging nosocomial pathogen in many parts
f the world. The aim of the present study was to review the
ncidence of Acinetobacter in several hospitals in Tehran,
ran and also to ﬁnd out pattern of antibiotic resistance of
cinetobacter. We published primary results of this study
hen it was consisted of 100 samples. It was accepted in
8th Annual ICAAC/ 46th Annual IDSA congress, Oct. 2008.
Methods: In a retrospective study we detected 800 posi-
ive cultures of Acinetobacter from 800 patients in different
ards of several tertiary care hospitals in Tehran, Iran. Disk
iffusion method was used to determine the resistance of
solated Acinetobacter baumannii. Antimicrobial sensitiv-
ty to 14 available antibiotics was analyzed. The following
ntibiotics were tested: cefriaxone, cefotaxime, cef-
azidime, cefepime, trimethoprim-sulfamethoxazole, gen-
amicin, tobramycin, amikacin, ciproﬂoxacine, oﬂoxacine,
mipenem, meropenem, piperacillin-tazobactam and tige-
ycline.
Results: The most frequently sites of infection were
ound, respiratry tract, blood stream, and urinary tract.
he most increminated wards were burn and intensive care
nit with a high prevalence of wound infection, pneumo-
ia and septicemia due to Acinetobacter. Acinetobacter was
solated from wound in 58.9%, tracheal discharge 9.2%, spu-
um in 7.1%, urine in 6.6%, blood in 5.8%, CSF in 3.4%, pleural
uid in 2%, tip of catheter (CV line) in 0.6% and brochoalve-
lar lavage (BAL) in 0.2%.
Acinetobacter baumannii showed resistance to cefri-
xone, cefotaxime, ceftazidime and cefepime more
han 90%. Resistance to gentamicin and trimethoprim-
ulfamethoxazole were more than 80%. Resistance to
mikacin, imipenem and ciproﬂoxacine were 72.7%,
0.5% and 45.7% respectively. Tigecycline, piperacillin-
azobactam, tobramycin and oﬂoxacine were evaluated in
00 samples. Sensitivity to tobramycin and oﬂoxacine were
8.9% and 25.3% respectively. Tigecycline and piperacillin-
azobactam were active against 100% and 74% of the strains
espectively.
Conclusion: Acinetobacter baumanii is an increasingly
solated pathogen in Iran. Prevalence of carbapenem resis-
ant acinetobacter is high in our study. Newer antimicrobial
ompound is needed for treatment of this infection.
oi:10.1016/j.ijid.2010.02.1567
